These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8791144)
1. Recovery from "end-stage" renal disease. Quérin S Int J Artif Organs; 1996 May; 19(5):263-4. PubMed ID: 8791144 [No Abstract] [Full Text] [Related]
2. The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure. Barnas U; Schmidt A; Haas M; Oberbauer R; Mayer G Nephrol Dial Transplant; 1996 Sep; 11(9):1822-4. PubMed ID: 8918629 [No Abstract] [Full Text] [Related]
3. Combination treatment and renal function in patients with chronic kidney disease. Renke M; Rutkowski P; Tylicki L; Rutkowski B J Renin Angiotensin Aldosterone Syst; 2010 Jun; 11(2):146-7. PubMed ID: 20223790 [No Abstract] [Full Text] [Related]
4. [Inhibition of the progression of renal failure in glomerular diseases]. Ritz E; Siebels M; Fliser D Internist (Berl); 1993 Apr; 34(4):330-9. PubMed ID: 8486477 [No Abstract] [Full Text] [Related]
5. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease. Kolesnyk I; Struijk DG; Dekker FW; Krediet RT Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies. Wenzel UO Contrib Nephrol; 2001; (135):200-11. PubMed ID: 11705285 [No Abstract] [Full Text] [Related]
7. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
8. [ACE inhibitors in kidney diseases--only another antihypertensive agent?]. Ritz E; Stein G Med Klin (Munich); 1994 Sep; 89(9):473-5. PubMed ID: 7968882 [No Abstract] [Full Text] [Related]
12. Angiotensin-converting enzyme inhibition: facts and fiction. Tamimi N; El Nahas AM Nephron; 2000 Apr; 84(4):299-304. PubMed ID: 10754405 [No Abstract] [Full Text] [Related]
13. The pros and cons of plasmapheresis therapy carried out on time. Izquierdo-Ortiz MJ; Mercado-Valdivia V; Camarero-Temiño V; Hijazi-Prieto B; Saiz-Calero I; Angola-Muquel MC; Muñoz-Merino M; Rodríguez-Velasco B; Abaigar-Luquin P Nefrologia; 2013; 33(5):741-2. PubMed ID: 24089171 [No Abstract] [Full Text] [Related]
14. Glomerular hypertension in the progression of chronic renal failure: role of low protein diet and angiotensin converting enzyme inhibitors. Cappelli P; Del Rosso G; Di Paolo B; Evangelista M; Albertazzi A Scand J Urol Nephrol Suppl; 1988; 108():25-30. PubMed ID: 3163827 [No Abstract] [Full Text] [Related]
15. The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design. Knoll GA; Cantarovitch M; Cole E; Gill J; Gourishankar S; Holland D; Kiberd B; Muirhead N; Prasad R; Tibbles LA; Treleaven D; Fergusson D Nephrol Dial Transplant; 2008 Jan; 23(1):354-8. PubMed ID: 17848393 [TBL] [Abstract][Full Text] [Related]
16. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067 [TBL] [Abstract][Full Text] [Related]
17. [Nephroprotection with ACE inhibitors]. Ritz E; Fliser D Verh Dtsch Ges Inn Med; 1991; 97():548-52. PubMed ID: 1808944 [No Abstract] [Full Text] [Related]